FRM
HCAT icon

Fox Run Management’s Health Catalyst HCAT Stock Holding History

Fox Run Management’s Portfolio HCAT Stock Details HCAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-30,576
Closed -$216K – 1032
2024
Q4 		$216K Buy
+30,576
New +$244K 0.04% 738
2024
Q1 		– Sell
-39,333
Closed -$364K – 895
2023
Q4 		$364K Buy
39,333
+22,886
+139% +$187K 0.09% 426
2023
Q3 		$166K Buy
+16,447
New +$196K 0.05% 588
2023
Q1 		– Sell
-13,358
Closed -$142K – 773
2022
Q4 		$142K Sell
13,358
-14,772
-53% -$143K 0.06% 533
2022
Q3 		$273K Buy
+28,130
New +$372K 0.11% 380

Other funds holding HCAT

FLAM
First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Impax Asset Management Group
Impax Asset Management Group London, United Kingdom $15.4B AUM 26.43% 1-Year Est. Return
NI
Nepsis Inc Minneapolis, Minnesota $317M AUM 37.22% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
WCA
Whetstone Capital Advisors Shawnee Mission, Kansas $380M AUM 20.01% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Fox Run Management's HCAT Position: Q1 2025 in Review

Fox Run Management sold out of Health Catalyst (HCAT) in Q1 2025, closing a stake of 30,576 shares — an estimated $216K sold.

Fox Run Management first reported a position in HCAT in Q3 2022 and held it in 5 quarters. The position peaked at $364K in Q4 2023. 165 funds tracked by Wall St. Rank hold HCAT as of Q1 2025.

  • Fox Run Management reported no remaining Health Catalyst position as of Q1 2025 after selling out during the quarter.
  • Fox Run Management sold 30,576 Health Catalyst shares in Q1 2025, an estimated $216K.
  • Fox Run Management first reported a position in Health Catalyst in Q3 2022 and held it in 5 quarters.
  • Fox Run Management's Health Catalyst position peaked at $364K in Q4 2023.
  • 165 funds tracked by Wall St. Rank held Health Catalyst as of Q1 2025.

Based on Fox Run Management's 13F filing for Q1 2025, filed 13 May 2025.